Список литературы

1. Hunskaar S, Lose G, Sykes D, Voss S. The prevalence of urinary incontinence in women in four European countries. BJU Int. - Feb 2004. - 93(3): 324 - 3.

2. Клинические рекомендации Российского общества урологов под редакцией Аляева, - М - 2017 г.

3. Harding, C., et al., EAU Guidelines on Management of Non-Neurogenic Female Lower Urinary Tract Symptoms, 2023.

4. Homma, Y., et al. Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score. Urology, 2011. 77: 60.

5. Brown, J.S., et al. Measurement characteristics of a voiding diary for use by men and women with overactive bladder. Urology, 2003. 61: 802.

6. Shy, M., et al. Objective Evaluation of Overactive Bladder: Which Surveys Should I Use? Curr Bladder Dysfunct Rep, 2013. 8: 45.

7. Arinzon, Z., et al. Clinical presentation of urinary tract infection (UTI) differs with aging in women. Arch Gerontol Geriatr, 2012. 55: 145.

8. Ouslander, J.G., et al. Does eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents? Ann Intern Med, 1995. 122: 749.

9. Goode, P.S., et al. Measurement of postvoid residual urine with portable transabdominal bladder ultrasound scanner and urethral catheterization. Int Urogynecol J Pelvic Floor Dysfunct, 2000. 11: 296.

10. Simforoosh N, Dadkhah F, Hosseini SY, Asgari MA, Nasseri A, Safarinejad MR. Accuracy of residual urine measurement in men: comparison between real-time ultrasonography and catheterization. J Urol. 1997; 158: 59 - 61.

11. Van Leijsen, S.A., et al. Can preoperative urodynamic investigation be omitted in women with stress urinary incontinence? A non-inferiority randomized controlled trial. Neurourol Urodyn, 2012. 31: 1118.

12. Bodmer N. S. et al. Randomised Controlled Trials Assessing the Clinical Value of Urodynamic Studies: A Systematic Review and Meta-analysis//European urology open science. - 2022. - T. 44. - С. 131 - 141.

13. Clement K. D. et al. Urodynamic studies for management of urinary incontinence in children and adults//Cochrane database of systematic reviews. - 2013. - N. 10.

14. Thiel, D.D., et al. Do clinical or urodynamic parameters predict artificial urinary sphincter outcome in post-radical prostatectomy incontinence? Urology, 2007. 69: 315. https://www.ncbi.nlm.nih.gov/pubmed/17320671.

15. Al Afraa, T., et al. Normal lower urinary tract assessment in women: I. Uroflowmetry and post-void residual, pad tests, and bladder diaries. Int Urogynecol J, 2012. 23: 681.

16. Scotti R. J. et al. Predictive value of urethroscopy as compared to urodynamics in the diagnosis of genuine stress incontinence//The Journal of reproductive medicine. - 1990. - T. 35. - N. 8. - С. 772 - 776.

17. Hadzi-Djokic, J., et al. Vesico-vaginal fistula: report of 220 cases. Int Urol Nephrol, 2009. 41: 299.

18. Sarma, A.V., et al. Risk factors for urinary incontinence among women with type 1 diabetes: findings from the epidemiology of diabetes interventions and complications study. Urology, 2009. 73: 1203.

19. Altman D. et al. Somatic comorbidity in women with overactive bladder syndrome//The Journal of urology. - 2016. - T. 196. - N. 2. - С. 473 - 477.

20. Brazzelli, M., et al. Absorbent products for containing urinary and/or fecal incontinence in adults. J Wound Ostomy Continence Nurs, 2002. 29: 45.

21. Moore, K.N., et al. Assessing comfort, safety, and patient satisfaction with three commonly used penile compression devices. Urology, 2004. 63: 150.

22. Fader, M., et al. Absorbent products for urinary/faecal incontinence: a comparative evaluation of key product designs. Health Technol Assess, 2008. 12: iii.

23. Bryant, C.M., et al. Caffeine reduction education to im Bryant, C.M., et al. Caffeine reduction education to improve urinary symptoms. Br J Nurs, 2002. 11: 560. prove urinary symptoms. Br J Nurs, 2002. 11: 560.

24. Hannestad, Y.S., et al. Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study. BJOG, 2003. 110: 247.

25. Imamura, M., et al. Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence. Health Technol Assess, 2010. 14: 1.

26. Glazener, C., et al. Urinary incontinence in men after formal one-to-one pelvic-floor muscle training following radical prostatectomy or transurethral resection of the prostate (MAPS): two parallel randomised controlled trials. Lancet, 2011. 378: 328.

27. Shamliyan, T.A., et al. Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med, 2008. 148: 459.

28. Rai, B.P., et al. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults. Cochrane Database Syst Rev, 2012. 12: CD003193.

29. Reynolds, W.S., et al. Comparative Effectiveness of Anticholinergic Therapy for Overactive Bladder in Women: A Systematic Review and Meta-analysis. Obstet Gynecol, 2015. 125: 1423.

30. Maman, K., et al. Comparative efficacy and safety of medical treatments for the management of overactive bladder: a systematic literature review and mixed treatment comparison. Eur Urol, 2014. 65: 7557 (https://www.ncbi.nlm.nih.gov/pubmed/24275310)

31. Buser, N., et al. Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses. Eur Urol, 2012. 62: 1040.

32. Novara, G., et al. A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol, 2008. 54: 740.

33. Millard, R., et al. Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity. J Urol, 1999. 161: 1551.

34. Chapple, C., et al. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial. BJU Int, 2014. 114: 418.

35. DuBeau, C.E., et al. Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials. Neurourol Urodyn, 2012. 31: 1258.

36. Sand, P.K., et al. Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged >/= 75 years) with overactive bladder syndrome. BJU Int, 2011. 107: 612.

37. Wesnes, K.A., et al. Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg. Expert Opin Drug Saf, 2009. 8: 615.

38. Herschorn, S., et al. A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the beta(3) adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder. Urology.

39. Chapple, C., et al. A Comparison of the Efficacy and Tolerability of Solifenacin Succinate and Extended Release Tolterodine at Treating Overactive Bladder Syndrome: Results of the STAR Trial. European Urology, 48 (2005), 464 - 470.

40. Khullar, V., et al. Efficacy and Tolerability of Mirabegron, a b3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European-Australian Phase 3 Trial. European Urology 63 (2013) 283 - 295.

41. Резолюция Экспертного Совета по Уродинамике и Нейроурологии секции Нейроурологии Российского Общества Урологов (РОУ), Урология, 2022, N 6, 134 - 136.

42. Cardozo L1, E, Milani R, P, Dewilde L, Slack M, Drogendijk T, Wright M, Bolodeoku J; SUNRISE Study Group. Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial. BJU Int. 2008 Nov; 102(9): 1120 - 7. doi: 10.1111/j.1464-410X.2008.07939.x. Epub 2008 Oct 6.

43. MacDiarmid, S., et al. Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy. J Urol, 2016. 196: 809 (http://www.ncbi.nlm.nih.gov/pubmed/27063854).

44. Пушкарь, Ю.А. Куприянов, С.И. Гамидов, Г.Г. Кривобородов, Л.Г. Спивак, С.Х. Аль-Шукри и др. Оценка безопасности и эффективности лекарственного препарата Везустен у пациентов с гиперактивным мочевым пузырем. Урология, 2022. 3: 42 - 51.

45. Green, A., et al. Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study. Drugs Aging. 2019 Mar; 36(3): 289 - 297. doi: 10.1007/s40266-018-00630-z. PMID: 30652263; PMCID: PMC6386184.

46. Методическое руководство Минздрава РФ "Фармакотерапия у лиц пожилого и старческого возраста", 2018.

47. Wagg, A., et al. Efficacy, safety, and tolerability of mirabegron in patients aged >= 65yr with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (PILLAR). Eur Urol. 2020 Feb; 77(2): 211 - 220. doi: 10.1016/j.eururo.2019.10.002. Epub 2019 Nov 13. PMID: 31733990.

48. Blok, B., et al. EAU Guidelines on Neuro-Urology, 2023.

49. Tannenbaum, C., et al. A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging, 2012. 29: 639. https://pubmed.ncbi.nlm.nih.gov/22812538/.

50. Boustani, M., et al. Impact of anticholinergics on the aging brain: A review and practical application. Aging Health (2008) 4(3), 311 - 320. DOI: 10.2217/1745509X.4.3.311.

51. Li, J., et al. The role of duloxetine in stress urinary incontinence: a systematic review and meta-analysis. Int Urol Nephrol, 2013. 45: 679.

52. Alan, C., et al. Efficacy of Duloxetine in the Early Management of Urinary Continence after Radical Prostatectomy. Curr Urol, 2015. 8: 43.

53. Yumru, A.E., et al. The use of local 17beta-oestradiol treatment for improving vaginal symptoms associated with post-menopausal oestrogen deficiency. J Int Med Res, 2009. 37: 198.

54. Cody, J.D., et al. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev, 2012. 10: CD001405.

55. Гаджиева З.К. Функциональное состояние нижних мочевых путей и медикаментозная коррекция нарушений мочеиспускания у женщин в климактерическом периоде. Дис ..... канд. мед. наук, 2001, 189 с.

56. Wang, C.J., et al. Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study. J Urol, 2011. 185: 219.

57. Urinary incontinence in women: management [CG171]. 2013, National Institute for Health and Care Excellence.

58. Vandersteen D. R., husmann D. A. Treatment of primary nocturnal enuresis persisting into adulthood//The Journal of urology. - 1999. - Т. 161. - N. 1. - С. 90 - 92.

59. Khan, Z.A., et al. Long-term follow-up of a multicentre randomised controlled trial comparing tension-free vaginal tape, xenograft and autologous fascial slings for the treatment of stress urinary incontinence in women. BJU Int, 2015. 115: 968.

60. Kenton, K., et al. 5-year longitudinal followup after retropubic and transobturator mid urethral slings. J Urol, 2015. 193: 203.

61. Ford, A.A., et al. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev, 2015: CD006375.

62. Pushkar D, Kasyan G, Gvozdev M, Sosnowski R. Analysis of 1,000 cases of synthetic midurethral slings used for treatment of female urinary incontinence - a single-center experience. Cent European J Urol. 2011; 64(4): 243 - 51.

63. Пушкарь Д.Ю., Касян Г.Р. Отдаленные результаты использования свободной синтетической петли в лечении недержания мочи у женщин (восьмилетние результаты). Пушкарь Д.Ю., Касян Г.Р.,//Урология. 2010. N 2. С. 32.

64. Novara, G., et al. Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence. Eur Urol, 2010. 58: 218.

65. Barber, M.D., et al. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. Am J Obstet Gynecol, 2008. 199: 666 e1.

66. Zhao, Y., et al., Bulking agents - An analysis of 500 cases and review of the literature. Clin Exp Obstet Gynecol, 2016. 43: 666.

67. Lapitan, M.C., et al. Open retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev, 2016. 2: CD002912.

68. Lee, K.S., et al. Outcomes following repeat mid urethral synthetic sling after failure of the initial sling procedure: rediscovery of the tension-free vaginal tape procedure. J Urol, 2007. 178: 1370.

69. van der Ploeg, J.M., et al. Transvaginal prolapse repair with or without the addition of a midurethral sling in women with genital prolapse and stress urinary incontinence: a randomised trial. BJOG, 2015. 122: 1022.

70. Borstad, E., et al. Surgical strategies for women with pelvic organ prolapse and urinary stress incontinence. Int Urogynecol J, 2010. 21: 179.

71. Maher, C., et al. Laparoscopic colposuspension or tension-free vaginal tape for recurrent stress urinary incontinence and/or urethral sphincter deficiency-a randomised controlled trial. Neurourol Urodyn., 2004. 23: 433.

72. Baessler K. et al. Surgery for women with pelvic organ prolapse with or without stress urinary incontinence//Cochrane Database of Systematic Reviews. - 2018. - N. 8.

73. Maher, C., et al. Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev, 2013: CD004014. https://www.ncbi.nlm.nih.gov/pubmed/23633316.

74. Pushkar DY, Godunov BN, Gvozdev M, Kasyan GR. Complications of midurethral slings for treatment of stress urinary incontinence. Int J Gynaecol Obstet. 2011 Apr; 113 (1): 54 - 7. doi: 10.1016/j. ijgo. 2010.10.024.

75. Bauer, R.M., et al. Contemporary management of postprostatectomy incontinence. Eur Urol, 2011. 59: 985.

76. Chung E. et al. Adjustable versus non-adjustable male sling for post-prostatectomy urinary incontinence: A prospective clinical trial comparing patient choice, clinical outcomes and satisfaction rate with a minimum follow up of 24 months//Neurourology an.

77. Imamoglu M. A. et al. The comparison of artificial urinary sphincter implantation and endourethral macroplastique injection for the treatment of postprostatectomy incontinence//European urology. - 2005. - Т. 47. - N. 2. - С. 209 - 213.

78. Bauer, R.M., et al. Mid-term results for the retroluminar transobturator sling suspension for stress urinary incontinence after prostatectomy. BJU Int, 2011. 108: 94.

79. Mangera, A., et al. Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA). Eur Urol, 2011. 60: 784.

80. Mehta, S., et al. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury. Arch Phys Med Rehabil, 2013. 94: 1473.

81. Chapple, C., et al. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial. Eur Urol.

82. Cohen, A.J., et al. Comparative Outcomes and Perioperative Complications of Robotic Vs Open Cystoplasty and Complex Reconstructions. Urology, 2016. 97: 172.

83. Weil E. H. J. et al. Sacral root neuromodulation in the treatment of refractory urinary urge incontinence: a prospective randomized clinical trial//European urology. - 2000. - Т. 37. - N. 2. - С. 161 - 171.

84. Schmidt R. A. et al. Sacral nerve stimulation for treatment of refractory urinary urge incontinence//The Journal of urology. - 1999. - Т. 162. - N. 2. - С. 352 - 357.

85. van Kerrebroeck, P.E., et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol, 2007. 178: 2029.

86. Heydari F., Motaghed Z., Abbaszadeh F. Could urinary tract infection cause female stress urinary incontinence? A clinical study//Nephro-Urology Monthly. - 2016. - Т. 8. - N. 1.

87. Bai A. D. et al. Presence of urinary symptoms in bacteremic urinary tract infection: a retrospective cohort study of Escherichia coli bacteremia//BMC Infectious Diseases. - 2020. - Т. 20. - N. 1. - С. 1 - 10.

88. Artibani W., Cerruto M. A. The role of imaging in urinary incontinence//BJU international. - 2005. - Т. 95. - N. 5. - С. 699 - 703.

89. Hall S. A. et al. Associations of commonly used medications with urinary incontinence in a community based sample//The Journal of urology. - 2012. - Т. 188. - N. 1. - С. 183 - 189.